Last reviewed · How we verify

NCT04161612: SLP

Sleep Quality & Spinal Cord Injury

Completed Last updated 16 December 2019
What this trial tests

trial testing Demographic characteristics, duration of spinal cord injury, spinal cord injurylevel, etiology, number of intermittent bladder catheterization (IC), number of night time in Sleep Disorder in 80 participants. Completed in 12 December 2019.

Timeline
10 November 2019
Primary endpoint
12 December 2019
12 December 2019

Quick facts

Lead sponsorIstanbul Physical Medicine Rehabilitation Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment80
Start date10 November 2019
Primary completion12 December 2019
Estimated completion12 December 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Who can join

Adults 18 to 65, any sex, with Sleep Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study was to evaluate sleep quality in patients with spinal cord injury; to investigate the relationship between sleep and spinal cord level, ambulation status, spasticity, quality of life, daily living activities, depressive status, neuropathic pain

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sleep Disorder

Currently open trials in the same condition.

Other Istanbul Physical Medicine Rehabilitation Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04161612.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing